Trevi Therapeutics
TRVI
TRVI
55 hedge funds and large institutions have $106M invested in Trevi Therapeutics in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 13 increasing their positions, 17 reducing their positions, and 4 closing their positions.
Holders
55
Holders Change
+2
Holders Change %
+3.77%
% of All Funds
0.88%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
13
Reduced
17
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
Legal & General Group
London,
United Kingdom
| $8.66K | – | – | – |
|
|
AIP
52
Ameritas Investment Partners
Lincoln,
Nebraska
| $7.5K | – | – | – |
|
|
NS
53
NBC Securities
Birmingham,
Alabama
| $4K | +$4K | +2,000 | New |
|
54
Fidelity Investments
Boston,
Massachusetts
| $3.44K | +$1.51K | +694 | +78% |
|
55
Citigroup
New York
| $94 | -$27K | -12,355 | -100% |
|
|
IAM
56
Innovis Asset Management
Chicago,
Illinois
| – | -$103K | -43,232 | Closed |
|
57
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$27.7K | -11,571 | Closed |
|
58
LPL Financial
San Diego,
California
| – | -$23.9K | -10,000 | Closed |
|
|
ZIM
59
Zacks Investment Management
Chicago,
Illinois
| – | -$23.9K | -10,000 | Closed |
|